Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1027 | 983 | 994 | 1362 | 1558 | 2326 |
Fund Return | 2.71% | -1.74% | -0.62% | 10.85% | 9.27% | 8.81% |
Place in category | 725 | 909 | 694 | 14 | 157 | 164 |
% in Category | 70 | 92 | 78 | 3 | 36 | 59 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Seligson Co Global Top 25 Brands Fu | 716M | 8.56 | 8.67 | 13.08 | ||
Seligson & Co Global Top 25 Brands | 716M | 8.56 | 8.66 | 13.04 | ||
Seligson North American B | 466.52M | 14.56 | 14.20 | 14.73 | ||
Seligson & Co North American A | 466.52M | 14.56 | 14.21 | 14.74 | ||
Seligson & Co Europe Index Fund A | 281.06M | 7.96 | 8.51 | 7.01 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Danske Invest MediLife T | 604.77K | 8.06 | 10.80 | 11.54 | ||
Danske Invest MediLife K | 90.6M | 8.06 | 10.79 | 11.54 | ||
Seligson Global Top 25 Pharmac B | 258.81M | 2.71 | 10.86 | 8.83 | ||
LahiTapiola Hyvinvointi A | 141.37M | 3.40 | 0.69 | 9.00 | ||
LahiTapiola Hyvinvointi B | 141.37M | 3.40 | 0.70 | 9.00 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Merck&Co | US58933Y1055 | 8.08 | 131.20 | +0.24% | |
Novartis | CH0012005267 | 6.53 | 93.37 | +0.81% | |
J&J | US4781601046 | 6.27 | 154.68 | +0.26% | |
Pfizer | US7170811035 | 6.02 | 28.64 | -0.95% | |
Roche Holding Participation | CH0012032048 | 5.60 | 237.10 | +0.98% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review